stabilized AT-4 agonistic peptide (Lanthio)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namestabilized AT-4 agonistic peptide (Lanthio)
Drug Alias Namestabilized angiotensin-4 agonistic peptide (Lanthio)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionAngiotensin II receptor agonists
TargetsAngiotensin II receptor
Therapy Area/IndicationsNervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLanthio Pharma Bv
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLanthio Pharma Bv
Active IndicationsN/A
Inactive IndicationsNervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A